Exploring the use of long-acting injectable HIV prevention among men who have sex with men in Baltimore
Extending the Prevention Toolbox: Exploring the Acceptability and Impact of Long-acting Injectable PrEP among MSM in Baltimore: A Pilot Study
This study is looking at how well men who have sex with men in Baltimore accept and use a new long-lasting HIV prevention shot, and it aims to understand what social factors might help or hinder its use in the community.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11098409 on NIH RePORTER |
What this research studies
This research investigates the acceptability and impact of long-acting injectable pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in Baltimore, where HIV incidence is notably high. The study aims to understand how social and structural factors influence the uptake of this innovative prevention method. By engaging with the community, the research will gather insights on perceptions and behaviors related to long-acting PrEP, particularly in high-risk populations. Participants will be asked about their experiences and attitudes towards this new form of HIV prevention, which could lead to improved strategies for increasing its use.
Who could benefit from this research
Good fit: Ideal candidates for this research are men who have sex with men living in Baltimore, particularly those at high risk for HIV.
Not a fit: Patients who do not identify as men who have sex with men or those not residing in Baltimore may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance HIV prevention strategies and reduce the incidence of HIV among high-risk populations.
How similar studies have performed: Previous studies have shown promise in exploring the acceptability of long-acting PrEP, but this specific approach in high-risk communities is relatively novel.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Dhir, Amit "Mickey" — Johns Hopkins University
- Study coordinator: Dhir, Amit "Mickey"
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.